Multiple myeloma in elderly patients: Presenting features and outcome

European Journal of Haematology

Volumn 66, Issue 1, 2001, Pages 11-17

  Rodon, Philippe ^a   Linassier, Claude ^b   Gauvain, Jean Bernard ^c   Benboubker, Lotfi ^b   Goupille, Philippe ^b   Maigre, Michel ^d   Luthier, François ^c   Dugay, Jacqueline ^e   Lucas, Virginie ^c   Colombat, Philippe ^b  

^a Centre Hospitalier Général   (France)

^b CHU BRETONNEAU   (France)

^c Centre Hospitalier Regional   (France)

^d Centre Hospitalier General   (France)

^e Centre Hospitalier General   (France)

Author keywords

Elderly; Multiple myeloma; Prognosis; Survival; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; MELPHALAN; PREDNISONE; VINCRISTINE; VINDESINE;

AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; FEMALE; GERIATRIC PATIENT; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAUSE OF DEATH; COMORBIDITY; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FEMALE; FRANCE; HUMANS; INTERFERON-ALPHA; LIFE TABLES; LOMUSTINE; MALE; MELPHALAN; MULTIPLE MYELOMA; MYELOMA PROTEINS; NEOPLASM STAGING; PARANEOPLASTIC SYNDROMES; PREDNIMUSTINE; PREDNISONE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 0035145279     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2001.00301.x     Document Type: Article

References (26)

1. The epidemiology of multiple myeloma
2. Incidence of multiple myeloma in Olmsted County, Minnesota: 1978 through 1990, with a review of the trend since 1945
3. Comparison of trends in the incidence of multiple myeloma in Malmö, Sweden, and other countries, 1950-1979
4. Multiple myeloma: Epidemiological features in a well-defined population in Burgundy, France
5. Has the incidence of multiple myeloma in old age been underestimated?
6. Epidemiologic and agedependant data on multiple myeloma in Austria
7. Age and the treatment of multiple myeloma
8. Treatment of multiple myeloma in elderly people: Long-term results
9. Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: Updated results of the MM87 prospective randomized protocol
10. Multiple myeloma in the geriatric patient
11. Multiple myeloma in the elderly: Clinical features and response to treatment in 113 patients
12. Improved survival duration with combination chemotherapy induction for multiple myeloma: A Southwest Oncology Group study
13. Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and trimethylene triphosphoramide
14. A clinical staging system for multiple myeloma
15. National Cancer Institute proposed guidelines for protocol studies. II. Plasma cell myeloma
16. Non-parametric estimation from incomplete observations
17. Evaluation of survival data and two new rank order statistics arising in its consideration
18. Regression models and life tables
19. Multiple myeloma: Review of 869 cases
20. C-Reactive protein and serum β2-microglobulin produce a simple and powerful myeloma staging system
21. Prognostic variables and clinical staging in multiple myeloma
22. Why better prognostic factors for multiple myeloma are needed
23. Multiple myeloma in the elderly
24. Chemotherapy of myeloma
25. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6633 patients from 27 randomized trials
26. Impact of response to treatment on survival in multiple myeloma: Results in a series of 243 patients